LIPI.ST Stock - Lipidor AB (publ)
Unlock GoAI Insights for LIPI.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $14,000 | $78,000 | $45,000 | $15.38M | $620,000 |
| Gross Profit | $-20,041,000 | $-6,449,000 | $-41,717,000 | $-21,107,000 | $-15,809,000 |
| Gross Margin | -143150.0% | -8267.9% | -92704.4% | -137.3% | -2549.8% |
| Operating Income | $-14,210,000 | $-15,454,000 | $-41,470,000 | $-21,384,000 | $-16,264,000 |
| Net Income | $-13,806,000 | $-11,485,000 | $-41,288,000 | $-21,195,000 | $-16,204,000 |
| Net Margin | -98614.3% | -14724.4% | -91751.1% | -137.8% | -2613.5% |
| EPS | $-0.03 | $-0.40 | $-1.42 | $-0.74 | $-0.66 |
Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, and AKP-03 AKP-07 for eczema. It offers active pharmaceutical ingredients used in products for various therapeutic applications, such as anti-psoriasic, antimicrobial, anti-inflammatory, antifungal, local anesthetics, non-steroidal anti-inflammatory, anti-acne, wound healing, anti-eczema, and anti-migraine. The company also develops a range of spray products for animal skin care in dogs, cats, and horses; and consumer health care products for applications, including antibacterial, antiseptic, moisturizing emollient, disinfectant, and acne and wart treatment. It has a collaboration agreement with Cannassure Therapeutics Ltd. for the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. The company was incorporated in 2009 and is based in Danderyd, Sweden.
Visit WebsiteEarnings History & Surprises
LIPI.STEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Dec 31, 2024 | — | $-0.03 | — | — |
Q3 2024 | Aug 28, 2024 | — | $-0.08 | — | — |
Q2 2024 | May 22, 2024 | — | $0.01 | — | — |
Q1 2024 | Feb 28, 2024 | — | $-0.18 | — | — |
Q4 2023 | Nov 22, 2023 | — | $-0.10 | — | — |
Q3 2023 | Aug 23, 2023 | — | $-0.13 | — | — |
Q2 2023 | May 11, 2023 | — | $0.01 | — | — |
Q1 2023 | Feb 22, 2023 | — | $-0.31 | — | — |
Q4 2022 | Nov 23, 2022 | — | $-0.42 | — | — |
Q3 2022 | Aug 24, 2022 | — | $-0.30 | — | — |
Q2 2022 | May 5, 2022 | — | $-0.38 | — | — |
Q1 2022 | Feb 23, 2022 | — | $-0.42 | — | — |
Q4 2021 | Nov 25, 2021 | — | $0.12 | — | — |
Q3 2021 | Aug 24, 2021 | — | $-0.26 | — | — |
Q2 2021 | May 6, 2021 | — | $-0.16 | — | — |
Q1 2021 | Feb 23, 2021 | — | $-0.21 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.23 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.12 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.12 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.22 | — | — |
Latest News
Frequently Asked Questions about LIPI.ST
What is LIPI.ST's current stock price?
What is the analyst price target for LIPI.ST?
What sector is Lipidor AB (publ) in?
What is LIPI.ST's market cap?
Does LIPI.ST pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to LIPI.ST for comparison